| 1 |
32154169 | Current Treatment and Outcomes Benchmark for Locally Advanced or Metastatic Urothelial Cancer From a Large UK-Based Single Centre. | 2020 |
1 |
| 2 |
32698410 | Treatment of Patients with Advanced Biliary Tract Cancer with Either Oxaliplatin, Gemcitabine, and Capecitabine or Cisplatin and Gemcitabine-A Randomized Phase II Trial. | 2020 Jul 20 |
2 |
| 3 |
31744064 | Retrospective Evaluation of Lung Adenocarcinoma Patients Progressing on 1st Line Chemotherapy. | 2019 Nov 16 |
1 |
| 4 |
29163710 | Combination of histoculture drug response assay and qPCR as an effective method to screen biomarkers for personalized chemotherapy in esophageal cancer. | 2017 Dec |
2 |
| 5 |
25925371 | Effects of JWA, XRCC1 and BRCA1 mRNA expression on molecular staging for personalized therapy in patients with advanced esophageal squamous cell carcinoma. | 2015 Apr 30 |
2 |
| 6 |
25111859 | Cisplatin/gemcitabine or oxaliplatin/gemcitabine in the treatment of advanced biliary tract cancer: a systematic review. | 2014 Dec |
2 |
| 7 |
10901311 | Intrinsic resistance to chemotherapeutic agents in murine osteosarcoma cells. | 2000 Jul |
1 |
| 8 |
8613443 | Experimental models for the study of drug resistance in osteosarcoma: P-glycoprotein-positive, murine osteosarcoma cell lines. | 1996 Mar |
1 |